Vacuum erection device in treatment of organic erectile dysfunction and penile vascular differences between patients with DM type I and DM type II
| Autor: | Milos Malidzan, Nikola Fatic, B. Pajovic, Marko Vukovic, A Dimitrovski |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male medicine.medical_specialty Vacuum Phosphodiesterase Inhibitors Sexual Behavior 030232 urology & nephrology Urology Hemodynamics Vacuum Erection Device Impotence Vasculogenic 03 medical and health sciences 0302 clinical medicine Quality of life Diabetes mellitus medicine Humans Prospective Studies Alprostadil Prospective cohort study Aged business.industry Middle Aged medicine.disease Surgery Diabetes Mellitus Type 1 medicine.anatomical_structure Erectile dysfunction Diabetes Mellitus Type 2 030220 oncology & carcinogenesis Quality of Life Geriatrics and Gerontology business Penis Artery |
| Zdroj: | The Aging Male. 20:49-53 |
| ISSN: | 1473-0790 1368-5538 |
| DOI: | 10.1080/13685538.2016.1230601 |
| Popis: | The aim of this study is to investigate changes in the vascular system and hemodynamics between patients with organic erectile dysfunction (ED) (DM type I and II), as well as to compare the quality of sexual life between those two groups after the treatment with vacuum erection device (VED). Study enrolled 50 males with DM, aged from 35 to 67 years, who have attended the urologic clinic due to inability to attain and maintain an erection of the penis sufficient to permit satisfactory sexual intercourse. Patients were using VED and six months later were assessed for therapy results. The International Index of Erectile Function (IIEF) was used to quantify erectile dysfunction. Alprostadil injection test was also used, with Doppler color flow imaging system, to evaluate the peak systolic velocity (PSV) and diameter of cavernosal artery (DCA). Significantly higher values of PSV were obtained in patients with DM type II. Also, DCA showed significant difference between two groups of patients. There was significant improvement in three items of IIEF after six months of treatment among both groups of examinees. Patients with DM type I had more serious risk for development of arteriogenic ED. VED could be a good alternative therapy for patients who denied peroral therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|